Skip to main content
Clinical Trials/NL-OMON55755
NL-OMON55755CompletedNot Applicable

Randomized trial for the evaluation of erectile dysfunction after whole or partial gland prostate brachytherapy: POWER (Partial or Whole gland for Erections) - POWER

Academisch Medisch Centrum0 sites65 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
65

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. Histologically adenocarcinoma on systematic prostate biopsies and targeted
  • biopsies after mpMRI
  • 2. Unilateral tumor confirmed by histology.
  • 3. Clinical stage T1c-T2b
  • 4. Gleason score 3 + 3 with >=30% tumor of all taken cores (ISUP Grade Group 1),
  • Gleason score 3 + 4 (ISUP Grade Group 2), and Gleason 4 + 3 (ISUP Grade Group
  • 5. PSA <=15 ng/ml and Gleason 7 (Grade Group 2-3) or PSA <=20 ng/mL and Gleason 6
  • (Grade Group 1)
  • 6. Baseline IIEF-5 score >=12
  • 7. Sexually active
  • 8. International Prostate Symptom Score (IPSS) <= 20
  • 9. WHO performance score <= 2
  • 10. Age > 18 years
  • 11. Written informed consent

Exclusion Criteria

  • 1. Contraindication for mpMRI
  • 2. Bleeding disorder preventing invasive treatment as a prostate implantation
  • 3. Not able to stop coumarine derivates
  • 4. Active urinary tract infection
  • 5. Any history of bladder neck stricture
  • 6. Comorbidity preventing general or spinal anesthesia
  • 7. Any history of inflammatory bowel disease
  • 8. Prior or concurrent malignancy except for non-melanoma skin cancer or other
  • malignancy from which the patient has been cured for at least 5 years
  • 9. Life expectancy of < 5 years
  • 10. Prostate calcifications greater than 5 mm
  • 11. Chemotherapy for prostate cancer
  • 12. Hormonal therapy for prostate cancer within 1 year prior to procedure
  • 13. Previous radiation to pelvis
  • 14. Recurrent prostate cancer
  • 15. Transurethral resection of the prostate or urethral stent
  • 16. Prior major rectal surgery (except haemorrhoids)

Investigators

Similar Trials